ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 36 filers reported holding ONCOLYTICS BIOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,173 | -35.4% | 9,712 | -21.6% | 0.00% | – |
| Q2 2023 | $32,789 | -88.5% | 12,386 | -94.8% | 0.00% | -100.0% |
| Q1 2023 | $285,524 | +2096.3% | 238,082 | +2757.4% | 0.00% | – |
| Q4 2022 | $13,000 | +30.0% | 8,332 | +11.2% | 0.00% | – |
| Q3 2022 | $10,000 | +25.0% | 7,490 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -27.3% | 7,490 | -6.6% | 0.00% | – |
| Q1 2022 | $11,000 | +175.0% | 8,017 | +170.7% | 0.00% | – |
| Q4 2021 | $4,000 | -33.3% | 2,962 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -50.0% | 2,962 | -33.6% | 0.00% | – |
| Q2 2021 | $12,000 | -25.0% | 4,462 | +12.6% | 0.00% | – |
| Q1 2021 | $16,000 | +128.6% | 3,962 | +33.8% | 0.00% | – |
| Q4 2020 | $7,000 | +16.7% | 2,962 | -2.2% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 3,029 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | -53.8% | 3,029 | -69.9% | 0.00% | – |
| Q1 2020 | $13,000 | – | 10,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 5,302,036 | $11,558,438 | 2.33% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 201,453 | $449,240 | 0.06% |
| BRAVE ASSET MANAGEMENT INC | 25,000 | $54,927 | 0.02% |
| Ausdal Financial Partners, Inc. | 20,000 | $43,600 | 0.01% |
| HEADINVEST, LLC | 11,534 | $24,106 | 0.01% |
| Cedar Mountain Advisors, LLC | 5,651 | $12,319 | 0.00% |
| Long Focus Capital Management, LLC | 40,000 | $87,200 | 0.00% |
| Banque Cantonale Vaudoise | 11,900 | $26 | 0.00% |
| OSAIC HOLDINGS, INC. | 9,712 | $21,173 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 33,485 | $72,997 | 0.00% |